No more than 75 million shares and no less than 50 million shares will be issued. The specific number shall be determined by the board of directors through consultation with the sponsors. The number of shares to be privately issued to a specific object in this offering shall not exceed 65,438+00 shares (excluding Chengdu Institute of Biological Products of China Biotechnology Group and Beijing Institute of Biological Products), and the subscribed shares shall not be transferred within 65,438+02 months. The scale of funds raised by non-public offering is not expected to exceed 654.38+05 billion yuan. The issue price shall not be less than 90% of the average price of the company's shares in the 20 trading days (June 25, 2008) before the announcement of the resolution of the board of directors. On May 9, 2008, the company implemented the plan of profit distribution and capitalization of capital reserve in 2007 (5 2 yuan shares for every 65,438+00 shares), and the final issue price was not less than 65,438+02.99 yuan/share. If the company's shares are ex-dividend during the period from the pricing base date to the issue date, the issue price will be adjusted accordingly. The specific issue price is determined by the board of directors authorized by the shareholders' meeting according to the issuer's subscription quotation and the principle of price priority.